Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /MANKIND
chevron_leftBack

Mankind Pharma Ltd.

MANKIND
NSE: MANKIND Delayed
2,545.50INR -1.3%
29.83 USD
As of 24 April 2025, Mankind Pharma Ltd. has a market cap of $12.47B USD, ranking #1410 globally and #88 in India. It ranks #119 in the Healthcare sector, and #16 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
1410
Country Rank
88
Sector Rank
119
Industry Rank
16
Key Stats
Market Cap
$12.47BUSD
1.06T INR
Enterprise Value
$12.0BUSD
1.02T INR
Revenue (TTM)
$1.36BUSD
116.41B INR
EBITDA (TTM)
$339.04MUSD
28.93B INR
Net Income (TTM)
$239.24MUSD
20.41B INR
EBITDA Margin
25%
Profit Margin
18%
PE Ratio
50.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sheetal Arora open_in_new
Employees
19,540
Founded
1991
Website
mankindpharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.3% 2% 6.4% 2.1% 0.2% 9.8%
Upcoming Earnings
Earnings Date
Thu, May 15

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
MANKIND
Mankind Pharma Ltd
ISIN: INE634S01028
Shares Out.:
412.579M1 Shares Float: 104.433M2
TV:
SA:
YF:
GF:
BA:
MS:
2.55K INR
Bombay Stock Exchange
MIC: XBOM
543904 (MANKIND)
Mankind Pharma Ltd
ISIN: INE634S01028
TV:
SA:
YF:
GF:
BA:
MS:
2.58K INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Mankind Pharma Ltd.

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. The company was incorporated in 1991 and is based in New Delhi, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
294%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
47%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
16%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
6%
Dr. Reddy's Laboratories Ltd.
DRREDDY
$11.47B
978.83B INR
-8%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
440%
Merck KGaA
MRK
$59.67B
52.43B EUR
378%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
271%
Haleon plc
HLN
$45.68B
34.34B GBP
266%
Galderma Group AG
GALD
$23.17B
19.13B CHF
86%